Profile
Paul H.
Bateman is currently Chief Executive Officer at ProVerum Ltd. since 2019.
Formerly, Mr. Bateman was Chief Executive Officer at Genosis Ltd. and Chief Executive Officer & Executive Director at Novate Medical Ltd. Mr. Bateman completed undergraduate education at The University of Manchester.
Paul H. Bateman active positions
| Companies | Position | Start |
|---|---|---|
ProVerum Ltd.
ProVerum Ltd. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of benign prostatic | Chief Executive Officer | 01/01/2019 |
Former positions of Paul H. Bateman
| Companies | Position | End |
|---|---|---|
Genosis Ltd. /GB/
Genosis Ltd. /GB/ Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Chief Executive Officer | - |
Novate Medical Ltd.
Novate Medical Ltd. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on the prevention of pulmonary embolism in venous thromboembolic events | Chief Executive Officer | - |
Genosis Ltd.
Genosis Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | President | - |
Training of Paul H. Bateman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genosis Ltd.
Genosis Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Genosis Ltd. /GB/
Genosis Ltd. /GB/ Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novate Medical Ltd.
Novate Medical Ltd. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on the prevention of pulmonary embolism in venous thromboembolic events | Health Technology |
ProVerum Ltd.
ProVerum Ltd. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of benign prostatic | Health Technology |
- Stock Market
- Insiders
- Paul H. Bateman
















